This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


The Pharmacotherapy of Panic Disorder

Mark H. Pollack, MD

Published: April 15, 2005

Article Abstract

Panic disorder is common and associated with significant morbidity and dysfunction. The pharmacologictreatment of panic disorder is aimed at reducing or eliminating panic attacks, avoidance behavior,anticipatory anxiety, and comorbid conditions—and substantially improving and normalizingoverall function and quality of life. Antidepressants and benzodiazepines remain the current mainstaysof pharmacotherapy for panic disorder, although other novel agents and strategies are becomingavailable and may add effective alternatives to the therapeutic armamentarium.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 66

Quick Links: Anxiety , Panic Disorder

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...